世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000036361

希少神経疾患治療の世界市場レポート(2023年)

The Business Research Company

Rare Neurological Disease Treatment Global Market Report 2023

発刊日 2023/09/27

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000036361

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、希少神経疾患治療の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている希少神経疾患治療市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 薬剤タイプ別
      ◇ 生物製剤
      ◇ 低分子
    ➣ 治療法別
      ◇ 認知行動療法
      ◇ 対人関係心理療法
      ◇ サイバーナイフ
      ◇ その他の治療法
    ➣ 投与方法別
      ◇ 経口薬
      ◇ 注射薬
      ◇ 他の投与経路
    ➣ 疾患別
      ◇ アイカルディ症候群
      ◇ アイカルディ・グティエール症候群
      ◇ 反射性交感神経性ジストロフィー症候群
      ◇ バッタリア・ネリ症候群
      ◇ クロイツフェルト・ヤコブ病
      ◇ 失認症
      ◇ その他の疾患
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局・ドラッグストア
      ◇ オンライン薬局
  • 調査企業
    ➣ Pfizer Inc.
    ➣ Johnson & Johnson Services Inc.
    ➣ F. Hoffmann-La Roche Ltd
    ➣ Bayer AG
    ➣ Merck & Co. Inc.
  • 調査国
    ➣ オーストラリア
    ➣ ブラジ
    ➣ 中国
    ➣ フランス
    ➣ ドイツ
    ➣ インド
    ➣ インドネシア
    ➣ 日本
    ➣ ロシア
    ➣ 韓国
    ➣ イギリス
    ➣ アメリカ
    ➣ カナダ
    ➣ イタリア
    ➣ スペイン
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Rare Neurological Disease Treatment Market Characteristics

3. Rare Neurological Disease Treatment Market Trends And Strategies

4. Rare Neurological Disease Treatment Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Rare Neurological Disease Treatment Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Rare Neurological Disease Treatment Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Rare Neurological Disease Treatment Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market

6. Rare Neurological Disease Treatment Market Segmentation
6.1. Global Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Biologics
Small Molecules
6.2. Global Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Cognitive Behavioral Therapy
Interpersonal Psychotherapy
Cyberknife
Other Therapies
6.3. Global Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oral
Injectable
Other Modes Of Administration
6.4. Global Rare Neurological Disease Treatment Market, Segmentation By Disorders, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Aicardi Syndrome
Aicardi-Goutieres Syndrome
Reflex Sympathetic Dystrophy Syndrome
Battaglia-Neri Syndrome
Creutzfeldt Jakob Disease
Agnosia
Other Disorders
6.5. Global Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital Pharmacies
Retail Pharmacies And Drug Store
Online Pharmacies

7. Rare Neurological Disease Treatment Market Regional And Country Analysis
7.1. Global Rare Neurological Disease Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Rare Neurological Disease Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Rare Neurological Disease Treatment Market
8.1. Asia-Pacific Rare Neurological Disease Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Rare Neurological Disease Treatment Market
9.1. China Rare Neurological Disease Treatment Market Overview
9.2. China Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Rare Neurological Disease Treatment Market
10.1. India Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Rare Neurological Disease Treatment Market
11.1. Japan Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Rare Neurological Disease Treatment Market
12.1. Australia Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Rare Neurological Disease Treatment Market
13.1. Indonesia Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Rare Neurological Disease Treatment Market
14.1. South Korea Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Rare Neurological Disease Treatment Market
15.1. Western Europe Rare Neurological Disease Treatment Market Overview
15.2. Western Europe Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Rare Neurological Disease Treatment Market
16.1. UK Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Rare Neurological Disease Treatment Market
17.1. Germany Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Rare Neurological Disease Treatment Market
18.1. France Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Italy Rare Neurological Disease Treatment Market
19.1. Italy Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Spain Rare Neurological Disease Treatment Market
20.1. Spain Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. Eastern Europe Rare Neurological Disease Treatment Market
21.1. Eastern Europe Rare Neurological Disease Treatment Market Overview
21.2. Eastern Europe Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. Russia Rare Neurological Disease Treatment Market
22.1. Russia Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. North America Rare Neurological Disease Treatment Market
23.1. North America Rare Neurological Disease Treatment Market Overview
23.2. North America Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. USA Rare Neurological Disease Treatment Market
24.1. USA Rare Neurological Disease Treatment Market Overview
24.2. USA Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Canada Rare Neurological Disease Treatment Market
25.1. Canada Rare Neurological Disease Treatment Market Overview
25.2. Canada Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. South America Rare Neurological Disease Treatment Market
26.1. South America Rare Neurological Disease Treatment Market Overview
26.2. South America Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Brazil Rare Neurological Disease Treatment Market
27.1. Brazil Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

28. Middle East Rare Neurological Disease Treatment Market
28.1. Middle East Rare Neurological Disease Treatment Market Overview
28.2. Middle East Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

29. Africa Rare Neurological Disease Treatment Market
29.1. Africa Rare Neurological Disease Treatment Market Overview
29.2. Africa Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

30. Rare Neurological Disease Treatment Market Competitive Landscape And Company Profiles
30.1. Rare Neurological Disease Treatment Market Competitive Landscape
30.2. Rare Neurological Disease Treatment Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson Services Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. F. Hoffmann-La Roche Ltd
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Bayer AG
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Merck & Co. Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Rare Neurological Disease Treatment Market Other Major And Innovative Companies
31.1. Abbvie Inc.
31.2. Novartis AG
31.3. Sanofi-Aventis SA
31.4. Bristol-Myers Squibb Company
31.5. AstraZeneca PLC
31.6. GlaxoSmithKline PLC
31.7. Takeda Pharmaceutical Company Limited
31.8. Medtronic PLC
31.9. Teva Pharmaceutical Industries Ltd.
31.10. CSL Limited
31.11. Biogen Inc.
31.12. UCB S.A.
31.13. Eisai Co. Ltd.
31.14. Otsuka Pharmaceutical Co. Ltd.
31.15. Jazz Pharmaceuticals PLC

32. Global Rare Neurological Disease Treatment Market Competitive Benchmarking

33. Global Rare Neurological Disease Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Rare Neurological Disease Treatment Market

35. Rare Neurological Disease Treatment Market Future Outlook and Potential Analysis
35.1 Rare Neurological Disease Treatment Market In 2027 - Countries Offering Most New Opportunities
35.2 Rare Neurological Disease Treatment Market In 2027 - Segments Offering Most New Opportunities
35.3 Rare Neurological Disease Treatment Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6: Global Rare Neurological Disease Treatment Market, Segmentation By Disorders, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7: Global Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8: Global Rare Neurological Disease Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9: Global Rare Neurological Disease Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10: Asia-Pacific, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11: Asia-Pacific, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12: Asia-Pacific, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13: China, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14: China, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15: China, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16: India, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17: India, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18: India, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19: Japan, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20: Japan, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21: Japan, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22: Australia, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23: Australia, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24: Australia, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25: Indonesia, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26: Indonesia, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27: Indonesia, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28: South Korea, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29: South Korea, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30: South Korea, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31: Western Europe, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32: Western Europe, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33: Western Europe, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34: UK, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35: UK, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36: UK, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37: Germany, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38: Germany, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39: Germany, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40: France, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41: France, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42: France, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43: Italy, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44: Italy, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45: Italy, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46: Spain, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 47: Spain, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 48: Spain, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 49: Eastern Europe, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 50: Eastern Europe, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 51: Eastern Europe, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 52: Russia, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 53: Russia, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 54: Russia, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 55: North America, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 56: North America, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 57: North America, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 58: USA, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 59: USA, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 60: USA, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 61: Canada, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 62: Canada, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 63: Canada, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 64: South America, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 65: South America, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 66: South America, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 67: Brazil, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 68: Brazil, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 69: Brazil, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 70: Middle East, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 71: Middle East, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 72: Middle East, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 73: Africa, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 74: Africa, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 75: Africa, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 76: Pfizer Inc. Financial Performance
Table 77: Johnson & Johnson Services Inc. Financial Performance
Table 78: F. Hoffmann-La Roche Ltd Financial Performance
Table 79: Bayer AG Financial Performance
Table 80: Merck & Co. Inc. Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3: Global Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4: Global Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5: Global Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6: Global Rare Neurological Disease Treatment Market, Segmentation By Disorders, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7: Global Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8: Global Rare Neurological Disease Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9: Global Rare Neurological Disease Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10: Asia-Pacific, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11: Asia-Pacific, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12: Asia-Pacific, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13: China, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14: China, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15: China, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16: India, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17: India, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18: India, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19: Japan, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20: Japan, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21: Japan, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22: Australia, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23: Australia, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24: Australia, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25: Indonesia, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26: Indonesia, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27: Indonesia, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28: South Korea, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29: South Korea, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30: South Korea, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31: Western Europe, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32: Western Europe, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33: Western Europe, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34: UK, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35: UK, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36: UK, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37: Germany, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38: Germany, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39: Germany, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40: France, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41: France, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42: France, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43: Italy, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44: Italy, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45: Italy, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46: Spain, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 47: Spain, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 48: Spain, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 49: Eastern Europe, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 50: Eastern Europe, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 51: Eastern Europe, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 52: Russia, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 53: Russia, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 54: Russia, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 55: North America, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 56: North America, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 57: North America, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 58: USA, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 59: USA, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 60: USA, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 61: Canada, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 62: Canada, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 63: Canada, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 64: South America, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 65: South America, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 66: South America, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 67: Brazil, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 68: Brazil, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 69: Brazil, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 70: Middle East, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 71: Middle East, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 72: Middle East, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 73: Africa, Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 74: Africa, Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 75: Africa, Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 76: Pfizer Inc. Financial Performance
Figure 77: Johnson & Johnson Services Inc. Financial Performance
Figure 78: F. Hoffmann-La Roche Ltd Financial Performance
Figure 79: Bayer AG Financial Performance
Figure 80: Merck & Co. Inc. Financial Performance

この商品のレポートナンバー

0000036361

TOP